post image

COVID-19 Oral Medicine Market: Investment & Growth Opportunity Analysis, 2023-2030

  • Report ID: 64205
  • Date: May, 2023
  • Pages: 139
  • Category: Healthcare & Pharmaceuticals

Global COVID-19 Oral Medicine Market Analysis & Forecast 2023-2030

Market Introduction

The global COVID-19 oral medicine market is expected to grow at a CAGR of around 10.5% during the forecast period of 2023-2030. The COVID-19 outbreak has caused havoc globally and affected millions of individuals. The pandemic outbreak has surged the need for the development of therapeutic solutions for treating it. COVID-19 can be treated using a range of drugs such as antivirals, monoclonal antibodies, and kinase inhibitors. The increasing investment by key players in the market serves as one of the major driving factors for the growth of the COVID-19 oral medicine market during the forecast period. For instance, in June 2022, Pfizer Inc. announced to strengthen its commitment to US manufacturing with a US$ 120 million investment at its Kalamazoo, Michigan, facility, enabling US-based production in support of its COVID-19 oral treatment, PAXLOVIDTM (nirmatrelvir and ritonavir).

In August 2021, the World Health Organization (WHO) released a report stating that Artesunate, imatinib, and infliximab are three new potential medications being investigated in the latest phase of the global Solidarity clinical trials to find effective COVID-19 therapies. In addition, medicines approved to be used in case of emergency include Eli Lilly and Company's monoclonal antibodies bamlanivimab with etesevimab; Regeneron's casirivimab and imdevimab; GlaxoSmithKline/Vir Biotechnology’s Xevudy (sotrovimab); Roche's Actemra; Celltrion's Regkirona; and convalescent plasma.

Market Segmentation

The global COVID-19 oral medicines market is segmented into drug class, distribution channel, end user, and region. Based on the drug class, the market is segmented into Antiviral, Anticoagulant, Monoclonal Antibodies, Immune Modulators, and Others (Sedatives, etc.). Antivirals emerged as the most popular medicines for COVID-19 in recent times. On the basis of distribution channels, the market is divided into offline and online. Moreover, based on the end users, the market is segmented into Hospitals, Clinics, Home Settings, and Others (Academic & Research Institutes). Geographically, the market is analyzed into North America, Western Europe, Eastern Europe, Asia Pacific, Latin America, Middle East & Africa.

Market Structure and Competition Landscape

Some of the key players in the global COVID-19 oral medicine market are Pfizer Inc., Merck & Co., Inc., Ridgeback Biotherapeutics, Strides Pharma Science Limited, Atea Pharmaceuticals, F. Hoffmann-La Roche Ltd., Emcure, Glenmark Pharmaceuticals Ltd., BioNTech SE, Dr. Reddy’s Laboratories Ltd., Novartis AG, Molecular Partners, among others. To maintain their market position, the key players in the COVID-19 oral medicine market focus on various growth strategies such as partnerships, collaborations, geographical expansion, product launches, etc. Some of the key developments in the COVID-19 oral medicine market include,

• In March 2021, Pfizer Inc. announced the initiation of a PHASE 1 study of a new oral antiviral therapeutic agent against SARS-COV-2.

• In October 2020, Atea Pharmaceuticals Inc. collaborated with Roche to jointly develop AT-527, a direct-acting antiviral (DAA), in Phase-2 clinical trials.

Global COVID-19 Oral Medicine Market Analysis and Forecast 2023-2030

Table of Contents

1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2023
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.1.1. Global Population Overview and Forecast
6.1.2. Per Capita Income by Selected Countries
6.1.3. Healthcare Expenditure by Selected Region/Countries
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players’ expenditures, and economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.3.1. Raw Material Suppliers
6.3.2. COVID-19 Oral Medicine Manufacturers
6.3.3. Key End Users
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter’s Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global COVID-19 Oral Medicine Market: Key Investment Analysis
9.1. By COVID-19 Oral Medicine Companies
9.2. By Region
9.3. M&A Activities
Robust assessment of major investments made by various industry players in the areas ranging from the application, key end users, etc.
10. Regional Penetration of COVID-19 Oral Medicine
10.1. North America
10.2. Latin America
10.3. Western Europe
10.4. Eastern Europe
10.5. Asia Pacific
10.6. Middle East & Africa
11. Pricing Analysis
11.1. By Product Type
11.2. By Region
11.2.1. North America
11.2.2. Western Europe
11.2.3. Eastern Europe
11.2.4. Asia Pacific
11.2.5. Latin America
11.2.6. Middle East & Africa
12. Parent Market Overview: Global Pharmaceutical and Healthcare Market
13. Segmental Analysis
13.1. Global COVID-19 Oral Medicine Market by Drug Class
13.1.1. Segment Overview
13.1.1.1. Antiviral
13.1.1.2. Monoclonal Antibodies
13.1.1.3. Anticoagulant
13.1.1.4. Other Drug Class (Glucocorticoid)
13.2. Global COVID-19 Oral Medicine Market by Region
13.2.1. North America
13.2.2. Latin America
13.2.3. Western Europe
13.2.4. Eastern Europe
13.2.5. Asia Pacific
13.2.6. Middle East & Africa
14. Regional Analysis
14.1. North America COVID-19 Oral Medicine Market Analysis and Forecast 2023-2030
14.1.1. Regional Market Overview and Key Takeaways
14.1.2. North America COVID-19 Oral Medicine Market by Drug Class
14.1.3. North America COVID-19 Oral Medicine Market by Distribution Channel
14.1.4. North America COVID-19 Oral Medicine Market by End User
14.1.5. North America COVID-19 Oral Medicine Market by Country
14.1.5.1. US
14.1.5.2. Canada
14.2. Latin America COVID-19 Oral Medicine Market Analysis and Forecast 2023-2030
14.2.1. Regional Market Overview and Key Takeaways
14.2.2. Latin America COVID-19 Oral Medicine Market by Drug Class
14.2.3. Latin America COVID-19 Oral Medicine Market by Distribution Channel
14.2.4. Latin America COVID-19 Oral Medicine Market by End User
14.2.5. Latin America COVID-19 Oral Medicine Market by Country
14.2.5.1. Brazil
14.2.5.2. Mexico
14.2.5.3. Rest of Latin America
14.3. Western Europe COVID-19 Oral Medicine Market Analysis and Forecast 2023-2030
14.3.1. Regional Market Overview and Key Takeaways
14.3.2. Western EuropeCOVID-19 Oral Medicine Market by Drug Class
14.3.3. Western EuropeCOVID-19 Oral Medicine Market by Distribution Channel
14.3.4. Western EuropeCOVID-19 Oral Medicine Market by End User
14.3.5. Western EuropeCOVID-19 Oral Medicine Market by Country
14.3.5.1. Germany
14.3.5.2. UK
14.3.5.3. France
14.3.5.4. Spain
14.3.5.5. Italy
14.3.5.6. Benelux
14.3.5.7. Nordic
14.3.5.8. Rest of Western Europe
14.4. Eastern Europe COVID-19 Oral Medicine Market Analysis and Forecast 2023-2030
14.4.1. Regional Market Overview and Key Takeaways
14.4.2. Eastern Europe COVID-19 Oral Medicine Market by Drug Class
14.4.3. Eastern Europe COVID-19 Oral Medicine Market by Distribution Channel
14.4.4. Eastern Europe COVID-19 Oral Medicine Market by End User
14.4.5. Eastern Europe COVID-19 Oral Medicine Market by Country
14.4.5.1. Russia
14.4.5.2. Poland
14.4.5.3. Rest of Eastern Europe
14.5. Asia Pacific COVID-19 Oral Medicine Market Analysis and Forecast 2023-2030
14.5.1. Regional Market Overview and Key Takeaways
14.5.2. Asia Pacific COVID-19 Oral Medicine Market by Drug Class
14.5.3. Asia Pacific COVID-19 Oral Medicine Market by Distribution Channel
14.5.4. Asia Pacific COVID-19 Oral Medicine Market by End User
14.5.5. Asia Pacific COVID-19 Oral Medicine Market by Country
14.5.5.1. China
14.5.5.2. Japan
14.5.5.3. India
14.5.5.4. South Korea
14.5.5.5. Australia
14.5.5.6. ASEAN
14.5.5.7. Rest of Asia-Pacific
14.6. Middle East & Africa COVID-19 Oral Medicine Market Analysis and Forecast 2023-2030
14.6.1. Regional Market Overview and Key Takeaways
14.6.2. Middle East & Africa COVID-19 Oral Medicine Market by Drug Class
14.6.3. Middle East & Africa COVID-19 Oral Medicine Market by Distribution Channel
14.6.4. Middle East & Africa COVID-19 Oral Medicine Market by End User
14.6.5. Middle East & Africa COVID-19 Oral Medicine Market by Country
14.6.5.1. GCC
14.6.5.2. South Africa
14.6.5.3. Turkey
14.6.5.4. Rest of the Middle East & Africa
15. Competitive Landscape
15.1. Competition Dashboard
15.1.1. Global and Regional Market Share Analysis
15.1.2. Market Structure by Geography
15.2. Competitive Benchmarking
15.3. Key Strategy Analysis
15.4. Company Profiles
15.4.1. Pfizer Inc.
15.4.1.1. Company Overview
15.4.1.2. Product/Service Offerings
15.4.1.3. Key Financials
15.4.1.4. Recent Developments
15.4.2. Merck & Co., Inc.
15.4.2.1. Company Overview
15.4.2.2. Product/Service Offerings
15.4.2.3. Financials
15.4.2.4. Recent Developments
15.4.3. Ridgeback Biotherapeutics
15.4.3.1. Company Overview
15.4.3.2. Product/Service Offerings
15.4.3.3. Financials
15.4.3.4. Recent Developments
15.4.4. Strides Pharma Science Limited
15.4.4.1. Company Overview
15.4.4.2. Product/Service Offerings
15.4.4.3. Financials
15.4.4.4. Recent Developments
15.4.5. Atea Pharmaceuticals
15.4.5.1. Company Overview
15.4.5.2. Product/Service Offerings
15.4.5.3. Financials
15.4.5.4. Recent Developments
15.4.6. F.Hoffmann-La Roche Ltd.
15.4.6.1. Company Overview
15.4.6.2. Product/Service Offerings
15.4.6.3. Financials
15.4.6.4. Recent Developments
15.4.7. Emcure
15.4.7.1. Company Overview
15.4.7.2. Product/Service Offerings
15.4.7.3. Financials
15.4.7.4. Recent Developments
15.4.8. Glenmark Pharmaceuticals Ltd.
15.4.8.1. Company Overview
15.4.8.2. Product/Service Offerings
15.4.8.3. Financials
15.4.8.4. Recent Developments
15.4.9. Dr. Reddy’s Laboratories Ltd.
15.4.9.1. Company Overview
15.4.9.2. Product/Service Offerings
15.4.9.3. Financials
15.4.9.4. Recent Developments
15.4.10. Novartis AG
15.4.10.1. Company Overview
15.4.10.2. Product/Service Offerings
15.4.10.3. Financials
15.4.10.4. Recent Developments
15.4.11. Molecular Partners
15.4.11.1. Company Overview
15.4.11.2. Product/Service Offerings
15.4.11.3. Financials
15.4.11.4. Recent Developments
15.4.12. Regeneron Pharmaceuticals, Inc.
15.4.12.1. Company Overview
15.4.12.2. Product/Service Offerings
15.4.12.3. Financials
15.4.12.4. Recent Developments
A comprehensive list of COVID-19 oral medicine manufacturers will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities
16. Disclaimer


List of Tables

Global COVID-19 Oral Medicine Market
List of Figures
Figure 01: Global COVID-19 Oral Medicine Market Volume (‘000 tons), 2019-2022
Figure 02: Global COVID-19 Oral Medicine Market Volume (‘000 tons) & Y-o-Y Growth (%) Analysis, 2023–2030
Figure 03: COVID-19 Oral Medicine, Pricing Analysis per unit (US$), in 2022
Figure 04: COVID-19 Oral Medicine, Pricing Forecast per unit (US$), in 2028
Figure 05: Global COVID-19 Oral Medicine Market Value Analysis (US$ Mn), 2019-2022
Figure 06: Global COVID-19 Oral Medicine Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2023–2030
Figure 07: Global COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Drug Class, 2023 & 2030
Figure 08: Global COVID-19 Oral Medicine Market Y-o-Y Analysis (%) by Drug Class, 2019-2028
Figure 09: Global COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Region, 2023 & 2030
Figure 10: Global COVID-19 Oral Medicine Market Y-o-Y Growth (%) by Region, 2023–2030
Figure 11: North America COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Drug Class, 2023 & 2030
Figure 12: North America COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 13: Latin America COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Drug Class, 2023 & 2030
Figure 14: Latin America COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 15: Western Europe COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Drug Class, 2023 & 2030
Figure 16: Western Europe COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 17: Eastern Europe COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Drug Class, 2023 & 2030
Figure 18: Eastern Europe COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 19: Asia Pacific COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Drug Class, 2023 & 2030
Figure 20: Asia Pacific COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 21: Middle East & Africa COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Drug Class, 2023 & 2030
Figure 22: Middle East & Africa COVID-19 Oral Medicine Market Size and Market Share Analysis (%) by Country, 2023 & 2030

List of Tables
Table 1: Global COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Drug Class
Table 2: Global COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Drug Class
Table 3: Global COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Region
Table 4: Global COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Region
Table 5: North America COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Drug Class
Table 6: North America COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Drug Class
Table 7: North America COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 8: North America COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Country
Table 9: Latin America COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Drug Class
Table 10: Latin America COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Drug Class
Table 11: Latin America COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 12: Latin America COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Country
Table 13: Western Europe COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Drug Class
Table 14: Western Europe COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Drug Class
Table 15: Western Europe COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 16: Western Europe COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Country
Table 17: Eastern Europe COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Drug Class
Table 18: Eastern Europe COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Drug Class
Table 19: Eastern Europe COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 20: Eastern Europe COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Country
Table 21: Asia Pacific COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Drug Class
Table 22: Asia Pacific COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Drug Class
Table 23: Asia Pacific COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 24: Asia Pacific COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Country
Table 25: Middle East & Africa COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Drug Class
Table 26: Middle East & Africa COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Drug Class
Table 27: Middle East & Africa COVID-19 Oral Medicine Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 28: Middle East & Africa COVID-19 Oral Medicine Market Volume (‘000 tons) Analysis and Forecast 2019-2028, by Country





List of Figures

Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.

In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.

This research methodology has been segmented into following types:

Primary Research:

It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.

Secondary Research:

The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.

Qualitative Research:

It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.

Quantitative Research:

It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.

Tab Four
Our Happy

Clients